Clonal heterogeneity of the sensitivity of human colon carcinoma cell lines to TGE beta isoforms
Related Experiment Videos
G H Zhou1, G L Sechrist, M G Brattain
1Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey 17033, USA.
Abstract:
Spontaneously arising, TGF beta 1-resistant colonies were isolated directly from the soft agarose plates of MOSER human colon carcinoma cells grown in the presence of TGF beta 1 but in the absence of serum. The colonies were cloned by limiting dilution and screened in a monolayer proliferation assay for sensitivity to TGF beta 1 and TGF beta 2 isoforms. Cell clones selectively sensitive or resistant to these isoforms in the growth inhibition assay displayed similar differential sensitivities to TGF beta isoforms for production of the extracellular matrix proteins laminin and fibronectin, as well as for the expression of the colon cell differentiation marker carcinoembryonic antigen. Differential receptor binding profiles for TGF beta 1 and TGF beta 2 were observed among the clones. The isolation of cell clones selectively resistant or sensitive to TGF beta isoforms as well as the identification of differential receptor binding profiles among the clones indicate the heterogeneity of TGF beta responsiveness that exists naturally in human colon tumor cells and stress the importance of defining mechanisms underlying differential responsiveness to TGF beta isoforms.
Insights
Researchers identified TGF-beta resistant colon cancer cells, revealing natural heterogeneity in tumor cell responses to TGF-beta isoforms. This highlights the need to understand varying TGF-beta signaling in cancer treatment.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Transforming growth factor-beta (TGF-β) plays a complex role in cancer, often acting as a tumor suppressor in early stages but promoting progression in later stages.
- Understanding differential responses to TGF-β isoforms is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To isolate and characterize human colon carcinoma cell clones with varying sensitivities to TGF-β1 and TGF-β2 isoforms.
- To investigate the relationship between TGF-β isoform sensitivity and cellular responses, including proliferation, extracellular matrix production, and differentiation marker expression.
Main Methods:
- Isolation of TGF-β1-resistant colonies from MOSER human colon carcinoma cells.
- Cloning by limiting dilution and screening in monolayer proliferation assays.
- Assessing sensitivity to TGF-β1 and TGF-β2 isoforms for growth inhibition, extracellular matrix protein production (laminin, fibronectin), and carcinoembryonic antigen (CEA) expression.
- Analyzing differential receptor binding profiles for TGF-β isoforms.
Main Results:
- Spontaneously arising TGF-β1-resistant colonies were successfully isolated.
- Cell clones exhibited selective sensitivity or resistance to TGF-β1 and TGF-β2 isoforms.
- Differential sensitivities to TGF-β isoforms correlated with variations in laminin and fibronectin production, and CEA expression.
- Distinct receptor binding profiles for TGF-β1 and TGF-β2 were observed among the isolated clones.
Conclusions:
- Human colon tumor cells naturally display heterogeneity in their responsiveness to TGF-β isoforms.
- Differential receptor binding contributes to the observed variations in TGF-β responsiveness.
- Further research is needed to elucidate the mechanisms underlying these differential responses to TGF-β isoforms in colon cancer.